Literature DB >> 33831368

Decoding the messaging of the ubiquitin system using chemical and protein probes.

Lukas T Henneberg1, Brenda A Schulman2.   

Abstract

Post-translational modification of proteins by ubiquitin is required for nearly all aspects of eukaryotic cell function. The numerous targets of ubiquitylation, and variety of ubiquitin modifications, are often likened to a code, where the ultimate messages are diverse responses to target ubiquitylation. E1, E2, and E3 multiprotein enzymatic assemblies modify specific targets and thus function as messengers. Recent advances in chemical and protein tools have revolutionized our ability to explore the ubiquitin system, through enabling new high-throughput screening methods, matching ubiquitylation enzymes with their cellular targets, revealing intricate allosteric mechanisms regulating ubiquitylating enzymes, facilitating structural revelation of transient assemblies determined by multivalent interactions, and providing new paradigms for inhibiting and redirecting ubiquitylation in vivo as new therapeutics. Here we discuss the development of methods that control, disrupt, and extract the flow of information across the ubiquitin system and have enabled elucidation of the underlying molecular and cellular biology.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E1; E2; E3; HECT; RBR; RING; RING-Cys-Relay; activity-based probe; thioester; ubiquitin; ubiquitin activating enzyme; ubiquitin conjugating enzyme; ubiquitin ligase

Mesh:

Substances:

Year:  2021        PMID: 33831368      PMCID: PMC7611516          DOI: 10.1016/j.chembiol.2021.03.009

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  120 in total

1.  Facile synthesis of covalent probes to capture enzymatic intermediates during E1 enzyme catalysis.

Authors:  Heeseon An; Alexander V Statsyuk
Journal:  Chem Commun (Camb)       Date:  2015-11-17       Impact factor: 6.222

Review 2.  The demographics of the ubiquitin system.

Authors:  Michael J Clague; Claire Heride; Sylvie Urbé
Journal:  Trends Cell Biol       Date:  2015-04-21       Impact factor: 20.808

3.  Discovery of Novel Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2-p53 Interaction.

Authors:  Andreas Gollner; Dorothea Rudolph; Heribert Arnhof; Markus Bauer; Sophia M Blake; Guido Boehmelt; Xiao-Ling Cockroft; Georg Dahmann; Peter Ettmayer; Thomas Gerstberger; Jale Karolyi-Oezguer; Dirk Kessler; Christiane Kofink; Juergen Ramharter; Jörg Rinnenthal; Alexander Savchenko; Renate Schnitzer; Harald Weinstabl; Ulrike Weyer-Czernilofsky; Tobias Wunberg; Darryl B McConnell
Journal:  J Med Chem       Date:  2016-11-15       Impact factor: 7.446

Review 4.  Enzyme inhibitor discovery by activity-based protein profiling.

Authors:  Micah J Niphakis; Benjamin F Cravatt
Journal:  Annu Rev Biochem       Date:  2014       Impact factor: 23.643

5.  Ubiquitin manipulation by an E2 conjugating enzyme using a novel covalent intermediate.

Authors:  Nadine Merkley; Kathryn R Barber; Gary S Shaw
Journal:  J Biol Chem       Date:  2005-07-12       Impact factor: 5.157

6.  Polyubiquitin-Photoactivatable Crosslinking Reagents for Mapping Ubiquitin Interactome Identify Rpn1 as a Proteasome Ubiquitin-Associating Subunit.

Authors:  Michal Chojnacki; Wissam Mansour; Dharjath S Hameed; Rajesh K Singh; Farid El Oualid; Rina Rosenzweig; Mark A Nakasone; Zanlin Yu; Fabian Glaser; Lewis E Kay; David Fushman; Huib Ovaa; Michael H Glickman
Journal:  Cell Chem Biol       Date:  2017-03-16       Impact factor: 8.116

7.  Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors.

Authors:  Philipp Holzer; Keiichi Masuya; Pascal Furet; Joerg Kallen; Therese Valat-Stachyra; Stéphane Ferretti; Joerg Berghausen; Michèle Bouisset-Leonard; Nicole Buschmann; Carole Pissot-Soldermann; Caroline Rynn; Stephan Ruetz; Stefan Stutz; Patrick Chène; Sébastien Jeay; Francois Gessier
Journal:  J Med Chem       Date:  2015-08-05       Impact factor: 7.446

8.  Ubiquitin adenylate: structure and role in ubiquitin activation.

Authors:  A L Haas; J V Warms; I A Rose
Journal:  Biochemistry       Date:  1983-09-13       Impact factor: 3.162

9.  Activity-Based Probes for HECT E3 Ubiquitin Ligases.

Authors:  Robert Byrne; Thomas Mund; Julien D F Licchesi
Journal:  Chembiochem       Date:  2017-06-28       Impact factor: 3.164

10.  In vivo modulation of ubiquitin chains by N-methylated non-proteinogenic cyclic peptides.

Authors:  Joseph M Rogers; Mickal Nawatha; Betsegaw Lemma; Ganga B Vamisetti; Ido Livneh; Uri Barash; Israel Vlodavsky; Aaron Ciechanover; David Fushman; Hiroaki Suga; Ashraf Brik
Journal:  RSC Chem Biol       Date:  2020-12-16
View more
  5 in total

1.  Activity-based probe profiling of RNF12 E3 ubiquitin ligase function in Tonne-Kalscheuer syndrome.

Authors:  Francisco Bustos; Sunil Mathur; Carmen Espejo-Serrano; Rachel Toth; C James Hastie; Satpal Virdee; Greg M Findlay
Journal:  Life Sci Alliance       Date:  2022-06-28

2.  Facile Preparation of UFMylation Activity-Based Probes by Chemoselective Installation of Electrophiles at the C-Terminus of Recombinant UFM1.

Authors:  Kateryna A Tolmachova; Jakob Farnung; Jin Rui Liang; Jacob E Corn; Jeffrey W Bode
Journal:  ACS Cent Sci       Date:  2022-05-17       Impact factor: 18.728

Review 3.  Role of circRNA in E3 Modification under Human Disease.

Authors:  Zishuo Chen; Minkai Song; Ting Wang; Jiawen Gao; Fei Lin; Hui Dai; Chao Zhang
Journal:  Biomolecules       Date:  2022-09-18

Review 4.  Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.

Authors:  Jinhui Guo; Jie Zhao; Wen Fu; Qiuran Xu; Dongsheng Huang
Journal:  Front Immunol       Date:  2022-07-20       Impact factor: 8.786

Review 5.  Non-lysine ubiquitylation: Doing things differently.

Authors:  Ian R Kelsall
Journal:  Front Mol Biosci       Date:  2022-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.